EGFR atypical mutation prevalence and outcome analysis in Chinese NSCLC patients
| Title | EGFR atypical mutation prevalence and outcome analysis in Chinese NSCLC patients |
|---|---|
| Description | The incidence of epidermal growth factor receptor (EGFR) mutations is relatively high in non-small cell lung cancer (NSCLC) patients. For NSCLC patients carrying atypical EGFR mutations, choosing targeted therapy remains a challenge, and more research is needed to develop effective treatment strategies to improve the survival rate and quality of life of these patients.Through data statistical analysis, describe the incidence of EGFR atypical mutation types in NSCLC patients who have received initial treatment and third-generation EGFR-TKI treatment, and explore the impact of EGFR atypical mutations on the efficacy of NSCLC patients receiving third-generation EGFR-TKI treatment. |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA031181 |
| Release Date | 2024-10-22 |
| Submitter | Yawen Ji (fanjh@origimed.com) |
| Organization | Shanghai OrigiMed Co. Ltd., |
| Submission Date | 2024-10-15 |
The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX007635-01 | Table sample for NSCLC EGFR projec | 1 | Other Type of Genomic Data | 46.1 KB | xlsx | 0 | Unavailable |